Line 40: | Line 40: | ||
<a href="https://2016.igem.org/Team:MIT/Collaborations"> | <a href="https://2016.igem.org/Team:MIT/Collaborations"> | ||
<img src="https://static.igem.org/mediawiki/2016/3/3d/T--MIT--Collaborations1.svg" alt="iGEM Collaborations" > | <img src="https://static.igem.org/mediawiki/2016/3/3d/T--MIT--Collaborations1.svg" alt="iGEM Collaborations" > | ||
− | <span class="text-content"><span><br><br><br><br><br><br><br>Read about how we worked with other iGEM teams throughout our project<br><br></span></span> | + | <span class="text-content"><span><br><br><br><br><br><br><br><br>Read about how we worked with other iGEM teams throughout our project<br><br></span></span> |
</a> | </a> | ||
</li> | </li> |
Revision as of 03:20, 17 October 2016
This diagnostic process can be expedited with synthetic biological tools that sense the following molecular markers in endometrial biopsy samples.
-
Read more about how we created synthetic promoters to respond to this disease marker
-
Read more about how we characterized miRNA profiles in model cells under varying conditions
-
Read more about how we characterized serine integrase TP901 that could give a circuit memory across a cycle
-
Read about a summary of our results and how our sensors interact logically after transfection of
4 to 5-unit genetic circuits into model cell cultures
-
Read about how we worked with other iGEM teams throughout our project
-
Read more about the future of our work through circuit design and clinical application